The mitogen-stimulating effect of the milk phospholipids under in vitro experiments

Authors

  • V. Gryshchenko ,

Abstract

The development of any disease causes pathological (inflammatory, dystrophic or degenerative) changes in cells. The severity of these changes depends on the reactivity of the organism, on the nature of the pathological influence and its duration, on the localization and distribution of the tissue changed area etc. A varied arsenal of medicinal agents is not enough focused on the repair of the structure and function of damaged cells, that is a serious lack of therapeutic schemes in the pathological states treatment. The main structural component of membranes are phospholipids, that’s why there is a reason to study the effectiveness of its use as agents for the reparative therapy, which are oriented on the recovery of the structural and functional state of the cell membranes and intracellular metabolism.

During in vitro experiment the proliferative that is regenerative effect of milk phospholipids in the form of the liposomal BAS FLP-MD in the peripheral white blood cells (lymphocytes) was investigated. For this purpose, the cultivation of lymphocytes of peripheral blood from healthy donors without the use of specific mitosis stimulators (for example phytohemagglutinin (PHA) was performed in control and research groups. In the culture medium of the research sample the FLP-MD BAS containing phospholipids was added.

The mitogen-stimulating (proliferative) effect of milk phospholipids in the form of the liposomal biologically active supplement FLP-MD on the peripheral blood cells of a donor was elicited during in vitro experiments. It confirms the phospholipids ability to accelerate reparative processes in damaged tissues. In other words, the specified biosupplement can be recommended as an agent for the cell reparative therapy.

Downloads

Issue

Vol. 7 No. 1-2 (2015): (англ)

Section

Статті

License

Relationship between right holders and users shall be governed by the terms of the license Creative Commons  Attribution – non-commercial – Distribution On Same Conditions 4.0 international (CC BY-NC-SA 4.0):https://creativecommons.org/licenses/by-nc-sa/4.0/deed.uk

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).